To include your compound in the COVID-19 Resource Center, submit it here.

Seattle Genetics falls after Adcetris panel

Seattle Genetics Inc. (NASDAQ:SGEN) fell $1.46 to $18.87 on Friday after a unanimous recommendation

Read the full 148 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE